医疗科技公司豪洛捷（Hologic）计划于2026年1月29日（周四）正式披露其2026财年第一季度的财务报告。此次业绩发布将全面展示公司在女性健康、诊断及外科手术解决方案等核心业务领域的经营表现。市场分析师普遍关注其分子诊断业务增长态势及国际市场的扩张进度。投资者可通过公司官网收听实时电话会议，管理层将现场解读财报细节并回应提问。
医疗科技公司豪洛捷（Hologic）计划于2026年1月29日（周四）正式披露其2026财年第一季度的财务报告。此次业绩发布将全面展示公司在女性健康、诊断及外科手术解决方案等核心业务领域的经营表现。市场分析师普遍关注其分子诊断业务增长态势及国际市场的扩张进度。投资者可通过公司官网收听实时电话会议，管理层将现场解读财报细节并回应提问。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.